Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'DEFIBROTIDE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 62 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Cella, G; Sbarai, A; Mazzaro, G; Motta, G; Carraro, P; Andreozzi, GM; Hoppensteadt, DA; Fareed, J
      Tissue factor pathway inhibitor release induced by defibrotide and heparins

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    2. Pegram, AA; Kennedy, LD
      Prevention and treatment of veno-occlusive disease

      ANNALS OF PHARMACOTHERAPY
    3. Aydin, H; Ercan, F; Cetinel, S; San, T
      Morphological examination of the effects of defibrotide on experimentally induced bladder injury and its relation to interstitial cystitis

      UROLOGICAL RESEARCH
    4. Jenner, MJ; Micallef, INM; Rohatiner, AZ; Kelsey, SM; Newland, AC; Cavenagh, JD
      Successful therapy of transplant-associated veno-occlusive disease with a combination of tissue plasminogen activator and defibrotide

      MEDICAL ONCOLOGY
    5. Bearman, SI
      Veno-occlusive disease of the liver

      CURRENT OPINION IN ONCOLOGY
    6. Aydemir, EO; Duman, C; Celik, HA; Turgan, N; Uysal, A; Mutaf, I; Habif, S; Ozmen, D; Nisli, N; Bayindir, O
      Effects of defibrotide on aorta and brain malondialdehyde and antioxidantsin cholesterol-induced atherosclerotic rabbits

      INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH

    7. Thrombotic thrombocytopenic purpura: now is the time for clinical trials

      HAEMATOLOGICA
    8. Uderzo, C; Fumagalli, M; De Lorenzo, P; Busca, A; Vassallo, E; Bonanomi, S; Lanino, E; Dini, G; Varotto, S; Messina, C; Miniero, R; Valsecchi, MG; Balduzzi, A
      Impact of thrombotic thrombocytopenic purpura on leukemic children undergoing bone marrow transplantation

      BONE MARROW TRANSPLANTATION
    9. San, T; Moini, H; Emerk, K; Bilsel, S
      Protective effect of defibrotide on perfusion induced endothelial damage

      THROMBOSIS RESEARCH
    10. Chopra, R; Eaton, JD; Grassi, A; Potter, M; Shaw, B; Salat, C; Neumeister, P; Finazzi, G; Iacobelli, M; Bowyer, K; Prentice, HG; Barbui, T
      Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study

      BRITISH JOURNAL OF HAEMATOLOGY
    11. Vingolo, EM; De Mattia, G; Giusti, C; Forte, R; Laurenti, O; Pannarale, MR
      Treatment of nonproliferative diabetic retinopathy with Defibrotide in noninsulin-dependent diabetes mellitus: A pilot study

      ACTA OPHTHALMOLOGICA SCANDINAVICA
    12. Girolami, B; Bernardi, E; Prins, MH; ten Cate, JW; Prandoni, P; Hettiarachchi, R; Marras, E; Stefani, PM; Girolami, A; Buller, HR
      Antithrombotic drugs in the primary medical management of intermittent claudication: A meta-analysis

      THROMBOSIS AND HAEMOSTASIS
    13. Abecasis, MM; Silva, JPC; Ferreira, I; Guimaraes, A; Machado, A
      Defibrotide as salvage therapy for refractory veno-occlusive disease of the liver complicating allogeneic bone marrow transplantation

      BONE MARROW TRANSPLANTATION
    14. SHIN YK; CAMPBELL B; LEFER AM
      NOVEL BENEFICIAL-EFFECTS OF DEFIBROTIDE, AN ENDOTHELIUM PROTECTING AGENT, FOLLOWING ISCHEMIA AND REPERFUSION IN THE ISOLATED-PERFUSED RAT-HEART

      Methods and findings in experimental and clinical pharmacology
    15. MCNAMARA DB; CHAMPION HC; KADOWITZ PJ
      PHARMACOLOGICAL MANAGEMENT OF PERIPHERAL VASCULAR-DISEASE

      The Surgical clinics of North America
    16. POLA P; DALLAGO A; FLORE R; DEMARTINI D; GAETANI E; GASBARRINI A; GERARDINO L; SANTOLIQUIDO A; TONDI P; SERRICCHIO M
      PHARMACOLOGICAL REDUCTION OF FACTOR-XIII ACTIVITY AND FIBRINOGENEMIA IN PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE

      Current therapeutic research
    17. MAISANO R; ADAMO V; TOSCANO G; CHIOFALO G; PERGOLIZZI S; SCIMONE A
      DEFIBROTIDE IN THE PREVENTION OF VENOUS IRRITATION BY VINORELBINE ADMINISTRATION

      Anticancer research
    18. BURRA P; FERRARESSO M; CADROBBI R; CALABRESE F; CARDIN R; PARNIGOTTO A; CARRARO P; RIGOTTI P
      EFFECT OF L-ARGININE AND OLIGOTIDE ON LIVER ISCHEMIA-REPERFUSION INJURY

      Transplantation proceedings
    19. COLONNA VD; ROSSONI G; BERNAREGGI M; MULLER EE; BERTI F
      CARDIAC ISCHEMIA AND IMPAIRMENT OF VASCULAR ENDOTHELIUM FUNCTION IN HEARTS FROM GROWTH HORMONE-DEFICIENT RATS - PROTECTION BY HEXARELIN

      European journal of pharmacology
    20. SALA M; LEONE MP; LAMPUGNANI P; MATTURRI L; GORI E
      POLYDEOXYRIBONUCLEOTIDE (DEFIBROTIDE) PROTECTS AGAINST POSTISCHEMIC BEHAVIORAL, ELECTROENCEPHALOGRAPHIC AND NEURONAL DAMAGE IN THE GERBIL

      European journal of pharmacology
    21. RADICE S; ROSSONI G; ORIANI G; MICHAEL M; CHIESARA E; BERTI F
      HYPERBARIC-OXYGEN WORSENS MYOCARDIAL LOW-FLOW ISCHEMIA-REPERFUSION INJURY IN ISOLATED RAT-HEART

      European journal of pharmacology
    22. BEARMAN SI; LEE JL; BARON AE; MCDONALD GB
      TREATMENT OF HEPATIC VENOCCLUSIVE DISEASE WITH RECOMBINANT HUMAN TISSUE-PLASMINOGEN ACTIVATOR AND HEPARIN IN 42 MARROW TRANSPLANT PATIENTS

      Blood
    23. FAREED J; JESKE W; CALLAS D; HOPPENSTEADT D; WALENGA J
      MODULATION OF ENDOTHELIUM BY HEPARIN AND RELATED POLYELECTROLYTES

      Clinical and applied thrombosis/hemostasis
    24. SCALIA R; KOCHILAS L; CAMPBELL B; LEFER AM
      EFFECTS OF DEFIBROTIDE ON LEUKOCYTE-ENDOTHELIAL CELL-INTERACTION IN THE RAT MESENTERIC VASCULAR BED - ROLE OF P-SELECTIN

      Methods and findings in experimental and clinical pharmacology
    25. ROSSONI G; SALA A; BUCCELLATI C; MACLOUF J; FOLCO GC; BERTI F
      VASOCONSTRICTION TO POLYMORPHONUCLEAR LEUKOCYTES IN THE ISOLATED, PERFUSED RABBIT HEART - INHIBITION BY PROSTACYCLIN MIMETICS

      Journal of cardiovascular pharmacology
    26. COCCHERI S; NAZZARI M
      DEFIBROTIDE AS A POSSIBLE ANTIISCHEMIC DRUG

      Seminars in thrombosis and hemostasis
    27. PASINI FL; FRIGERIO C; CAPECCHI PL; CECCATELLI L; MESSA GL; FRANCHI M; DIPERRI T
      MODULATION OF VENOUS ENDOTHELIAL ACTIVITY AND TRANSCELLULAR CALCIUM-TRANSPORT BY DEFIBROTIDE - THE ADENOSINE HYPOTHESIS

      Seminars in thrombosis and hemostasis
    28. ULUTIN ON; BALKUVULUTIN S; BEZERGOKER B; CIZMECI G; FERHANOGLU B; OZSOY Y; UGUR MS; ULUTIN T; YAMAN A; YARDIMCI T
      EFFECT OF DEFIBROTIDE ON PLATELET-FUNCTION

      Seminars in thrombosis and hemostasis
    29. CIMMINIELLO C
      CLINICAL-TRIALS WITH DEFIBROTIDE IN VASCULAR DISORDERS

      Seminars in thrombosis and hemostasis
    30. STRANO A; HOPPENSTEADT D; WALENGA JM; FAREED J; SABBA C; BERARDI E; ALLEGRA C; CARLIZZA A; BINAGHI F; FRONTEDDU F; DELGUERCIO R; DELGUERCIO M; PINTO A; ALLETTO G; NAZZARI M; FERRARI PA
      PLASMA-LEVELS OF THE MOLECULAR MARKERS OF COAGULATION AND FIBRINOLYSIS IN PATIENTS WITH PERIPHERAL ARTERIAL-DISEASE

      Seminars in thrombosis and hemostasis
    31. PESCADOR R; PORTA R; FERRO L
      AN INTEGRATED VIEW OF THE ACTIVITIES OF DEFIBROTIDE

      Seminars in thrombosis and hemostasis
    32. YANG LH; HOPPENSTEADT DA; IQBAL O; FAREED J
      DEFIBROTIDE MEDIATED INHIBITION OF SEROTONIN, ENDOTHELIN-I, THROMBOXANE, AND SERUM-INDUCED CONTRACTION OF CANINE FEMORAL AND PULMONARY ARTERIAL RINGS

      Thrombosis research
    33. FISHER J; HOLLAND TK; PESCADOR R; PORTA R; FERRO L
      STUDY ON PHARMACOKINETICS OF RADIOACTIVE LABELED DEFIBROTIDE AFTER ORAL OR INTRAVENOUS ADMINISTRATION IN RATS

      Thrombosis research
    34. MARNI A; FORTI D; CAVILLO L; GAJA G; FERRERO ME
      PROTECTION OF RAT-KIDNEY FROM ISCHEMIA-REPERFUSION INJURY BY OLIGOTIDE

      Transplantation proceedings
    35. FACINO RM; CARINI M; ALDINI G; BERTI F; ROSSONI G; BOMBARDELLI E; MORAZZONI P
      PROCYANIDINES FROM VITIS-VINIFERA SEEDS PROTECT RABBIT HEART FROM ISCHEMIA-REPERFUSION INJURY - ANTIOXIDANT INTERVENTION AND OR IRON AND COPPER SEQUESTERING ABILITY/

      Planta medica
    36. SCALIA R; GAUTHIER TW; MUROHARA T; LEFER AM
      OLIGOTIDE ATTENUATES LEUKOCYTE-ENDOTHELIAL CELL-INTERACTION VIA P-SELECTIN IN THE RAT MESENTERIC VASCULAR BED

      European journal of pharmacology
    37. PELLEGATTA F; LU Y; RADAELLI A; ZOCCHI MR; FERRERO E; CHIERCHIA S; GAJA G; FERRERO ME
      DRUG-INDUCED IN-VITRO INHIBITION OF NEUTROPHIL-ENDOTHELIAL CELL-ADHESION

      British Journal of Pharmacology
    38. MUROHARA T; BUERKE M; LEFER AM
      CARDIOPROTECTIVE ACTIONS OF OLIGOTIDE, A SINGLE-STRANDED POLYDEOXYRIBONUCLEOTIDE COMPLEX, IN MYOCARDIAL-ISCHEMIA AND REPERFUSION INJURY

      British Journal of Pharmacology
    39. HAKLAR G; ERSAHIN C; MOINI H; SUNGUN M; DOGAN N; BILSEL S; EMERK K; YALCIN AS
      INVOLVEMENT OF FREE-RADICALS IN THE CARDIOPROTECTIVE EFFECT OF DEFIBROTIDE

      Arzneimittel-Forschung
    40. YARDIMCI T; YAMAN A; ULUTIN O
      CHARACTERIZATION OF PLATELET GAMMA-GLUTAMYLTRANSFERASE AND ITS ALTERATION IN CASES OF ATHEROSCLEROSIS

      Clinical and applied thrombosis/hemostasis
    41. SKURK C; NUSS C; LEFER AM
      BENEFICIAL-EFFECTS OF OLIGOTIDE, A NOVEL OLIGODEOXYRIBONUCLEOTIDE, INMURINE TRAUMATIC SHOCK

      Shock
    42. ROSSONI G; BERTI F; BERNAREGGI M; VILLA L; AGOZZINO S; CEREDA R; GIULIANI P; MIZRAHI J
      PROTECTIVE EFFECTS OF ITF-296 IN THE ISOLATED RABBIT HEART SUBJECTED TO GLOBAL-ISCHEMIA

      Journal of cardiovascular pharmacology
    43. ABBATE R; GORI AM; MARTINI F; ATTANASIO M; COMEGLIO P; GIUSTI B; ZARONE N; FRANCALANCI I; PRISCO D; GENSINI GF
      DEFIBROTIDE(R) REDUCES MONOCYTE PAI-2 AND PROCOAGULANT ACTIVITY

      Seminars in thrombosis and hemostasis
    44. ALBERICO P; PORTA R; PESCADOR R; FERRO L
      IS DEFIBROTIDES ACTIVITY ON LEUKOCYTES ADENOSINE-RECEPTOR MEDIATED - AN IN-VITRO EX-VIVO APPRAISAL

      Thrombosis research
    45. ROSSONI G; BERTI F; BERTI M; BERNAREGGI M; TRENTO F; PORTA R; PESCADOR R; FERRO L
      OLIGOTIDE, A NEW SINGLE-STRANDED OLIGODEOXYRIBONUCLEOTIDE, PRESERVES POSTSYNAPTIC BETA-ADRENERGIC AND CHOLINERGIC RECEPTOR FUNCTIONS IN RABBIT HEARTS AFTER ACUTE INFARCTION

      Thrombosis research
    46. RIGOTTI P; FERRARESSO M; MORPURGO E; CADROBBI R; MENON F; BACELLE L; CALABRESE F; VALENTE ML; GATTA A; ANCONA E
      PREVENTION OF RENAL ISCHEMIC DAMAGE BY ENDOTHELIAL PROTECTING AGENTS

      Transplantation proceedings
    47. PESCADOR R; TETTAMANTI R; SALVETTI L; CONTO A; BARONE D; PORTA R; MANTOVANI M; FERRO L
      EFFECTS OF DEFIBROTIDE ON LEUKOCYTOSIS IN RABBITS WITH DIET-INDUCED ATHEROSCLEROSIS

      Life sciences
    48. MASINI E; LUPINI M; MUGNAI L; RASPANTI S; MANNAIONI PF
      POLYDEOXYRIBONUCLEOTIDES AND NITRIC-OXIDE RELEASE FROM GUINEA-PIG HEARTS DURING ISCHEMIA AND REPERFUSION

      British Journal of Pharmacology
    49. MARRAPODI E; LEANZA D; GIORDANO S; NAZZARI M; CORSI C
      EFFECTS OF DEFIBROTIDE ON PHYSICAL PERFORMANCE AND HEMORHEOLOGIC PICTURE IN PATIENTS WITH PERIPHERAL ARTERIOPATHY

      Clinical trials and meta-analysis
    50. CAIMI G; LOPRESTI R; MONTANA M; CANINO B; GRIFO G; FRANCAVILLA G; SARNO A
      EFFECT OF INTRAVENOUS DEFIBROTIDE ON HEMORHEOLOGIC PARAMETERS IN PATIENTS WITH VASCULAR ATHEROSCLEROTIC DISEASE

      Advances in therapy
    51. CESARONE MR; LAURORA G; DESANCTIS MT; INCANDELA L; BELCARO G
      VASOSPASM IN PATIENTS WITH INTERMITTENT CLAUDICATION - EFFECTS OF DEFIBROTIDE AND ACETYLSALICYLIC-ACID

      Advances in therapy
    52. HIZAL N; BILSEL S; EMERK K
      INVESTIGATION OF THE FIBRINOLYTIC-ACTIVITY OF DEFIBROTIDE FRACTIONS

      General pharmacology
    53. BILSEL S; SAN T; ERSAHIN C; MOINI H; OKAR I; EMERK K
      MORPHOLOGICAL-CHANGES IN CAROTID ARTERIES OF INDUCED BY DEFIBROTIDE INFUSION

      Thrombosis research
    54. LAURORA G; AMBROSOLI L; CESARONE MR; DESANCTIS MT; INCANDELA L; MARELLI C; BELCARO G
      TREATMENT OF INTERMITTENT CLAUDICATION WITH DEFIBROTIDE OR MESOGLYCAN- A DOUBLE-BLIND-STUDY

      Panminerva Medica
    55. GRODZINSKA L; OLSZEWSKI E; KOSTKATRABKA E; TUREK J; BIERON K; GOSZCZ A; SLAWINSKI M; RERON E
      EFFECTIVE DEFIBROTIDE THERAPY IN PATIENTS WITH RAPID PROGRESSIVE HEARING-LOSS

      Journal of drug development
    56. TUBARO M; MATTIOLI G; MATTA F; CAPPELLO C; NATALE E; RICCI R; GERARDI P; MILAZZOTTO F
      DEFIBROTIDE VERSUS HEPARIN IN THE PREVENTION OF CORONARY REOCCLUSION AFTER THROMBOLYSIS IN ACUTE MYOCARDIAL-INFARCTION

      Cardiovascular drugs and therapy
    57. COMANDELLA MG; RIGOTTI P; VALENTE M; PITTONI G; BALDAN N; GANZ E; AMODIO P; ANCONA E
      FUNCTIONAL AND MORPHOLOGICAL EFFECTS OF DEFIBROTIDE ON RENAL ISCHEMIA

      Research in experimental medicine
    58. BERTI F; ROSSONI G; DELLABELLA D; VILLA LM; BUSCHI A; TRENTO F; BERTI M; TONDO C
      NITRIC-OXIDE AND PROSTACYCLIN INFLUENCE CORONARY VASOMOTOR TONE IN PERFUSED RABBIT HEART AND MODULATE ENDOTHELIN-1 ACTIVITY

      Journal of cardiovascular pharmacology
    59. BACHER P; KINDEL G; WALENGA JM; FAREED J
      MODULATION OF ENDOTHELIAL AND PLATELET-FUNCTION BY A POLYDEOXYRIBONUCLEOTIDE DERIVED DRUG DEFIBROTIDE - A DUAL MECHANISM IN THE CONTROL OF VASCULAR PATHOLOGY

      Thrombosis research
    60. FISHER J; JOHNSTON AM; HOLLAND TK; MCCALLUM J; PESCADOR R; MANTOVANI M; PRINO G
      PHARMACOKINETICS, ABSORPTION, DISTRIBUTION AND DISPOSITION OF [I-125]DEFIBROTIDE FOLLOWING INTRAVENOUS OR ORAL-ADMINISTRATION IN THE RAT

      Thrombosis research
    61. BIANCHI G; BARONE D; LANZAROTTI E; TETTAMANTI R; PORTA R; MOLTRASIO D; CEDRO A; SALVETTI L; MANTOVANI M; PRINO G
      DEFIBROTIDE, A SINGLE-STRANDED POLYDEOXYRIBONUCLEOTIDE ACTING AS AN ADENOSINE RECEPTOR AGONIST

      European journal of pharmacology
    62. PAUL W; GRESELE P; MOMI S; BIANCHI G; PAGE CP
      THE EFFECT OF DEFIBROTIDE ON THROMBOEMBOLISM IN THE PULMONARY VASCULATURE OF MICE AND RABBITS AND IN THE CEREBRAL VASCULATURE OF RABBITS

      British Journal of Pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/08/20 alle ore 13:23:10